Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma

Rajagopalan Sudha, Nicole Kawachi, Peicheng Du, Edward Nieves, Thomas J. Belbin, Abdissa Negassa, Ruth Hogue Angeletti, Michael B. Prystowsky

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The goal of this study was to establish a method for detecting biologically significant differences in protein expression of head and neck squamous cell carcinoma (HNSCC) obtained from the same samples utilized in gene expression analyses. Proteins from two head and neck tumor cell lines, SCC-25 and FaDu, were isolated from the denatured protein solution remaining from the TRIzol extraction procedure used for isolation of total RNA for microarray analysis. Peptides resulting from chemical and enzymatic digestion of the proteins were first separated by strong cation-exchange chromatography, followed by liquid chromatography-mass spectrometry (LC-MS) analysis on a QqTOF mass spectrometer. Stable isotope-labeled synthetic peptides were added to each ion-exchange fraction as internal standards, for reversed-phase HPLC retention time alignment. Protein extraction and digestion were repeated three times for each cell line and each extract was analyzed three times by LC-MS. To discriminate between technical vs biological variation, the ion-exchange fraction, retention time, normalized mass and signal intensity of these nine data sets were constructed into numerical arrays for statistical analysis. Of the ∼50 000 signals, 90 peptide ions were found to discriminate the two cell lines with high stringency. Of those, six peptides were derived from vimentin and four peptides were derived from annexin II; both expressed more in SCC-25. Follow-up analysis of some of these signals by LC-MS/MS and RNA expression profiling revealed both concordance and discordance of RNA and protein expression. This study demonstrates that this procedure is highly reliable for identifying peptides that distinguish biological variability among samples, indicating that this method can be applied to study clinical samples, to identify potential prognostic biomarkers for HNSCC.

Original languageEnglish (US)
Pages (from-to)755-766
Number of pages12
JournalLaboratory Investigation
Volume87
Issue number8
DOIs
StatePublished - Aug 11 2007

Fingerprint

Proteomics
Squamous Cell Carcinoma
Neck
Head
Peptides
Liquid Chromatography
Mass Spectrometry
Ion Exchange
RNA
Proteolysis
Proteins
Annexin A2
Cell Line
Vimentin
Microarray Analysis
Protein Sorting Signals
Tumor Cell Line
Isotopes
Cations
Chromatography

Keywords

  • Biomarker
  • Cancer
  • Global proteomics
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. / Sudha, Rajagopalan; Kawachi, Nicole; Du, Peicheng; Nieves, Edward; Belbin, Thomas J.; Negassa, Abdissa; Angeletti, Ruth Hogue; Prystowsky, Michael B.

In: Laboratory Investigation, Vol. 87, No. 8, 11.08.2007, p. 755-766.

Research output: Contribution to journalArticle

Sudha, Rajagopalan ; Kawachi, Nicole ; Du, Peicheng ; Nieves, Edward ; Belbin, Thomas J. ; Negassa, Abdissa ; Angeletti, Ruth Hogue ; Prystowsky, Michael B. / Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. In: Laboratory Investigation. 2007 ; Vol. 87, No. 8. pp. 755-766.
@article{b504c42a70394008a1ff9228a114a555,
title = "Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma",
abstract = "The goal of this study was to establish a method for detecting biologically significant differences in protein expression of head and neck squamous cell carcinoma (HNSCC) obtained from the same samples utilized in gene expression analyses. Proteins from two head and neck tumor cell lines, SCC-25 and FaDu, were isolated from the denatured protein solution remaining from the TRIzol extraction procedure used for isolation of total RNA for microarray analysis. Peptides resulting from chemical and enzymatic digestion of the proteins were first separated by strong cation-exchange chromatography, followed by liquid chromatography-mass spectrometry (LC-MS) analysis on a QqTOF mass spectrometer. Stable isotope-labeled synthetic peptides were added to each ion-exchange fraction as internal standards, for reversed-phase HPLC retention time alignment. Protein extraction and digestion were repeated three times for each cell line and each extract was analyzed three times by LC-MS. To discriminate between technical vs biological variation, the ion-exchange fraction, retention time, normalized mass and signal intensity of these nine data sets were constructed into numerical arrays for statistical analysis. Of the ∼50 000 signals, 90 peptide ions were found to discriminate the two cell lines with high stringency. Of those, six peptides were derived from vimentin and four peptides were derived from annexin II; both expressed more in SCC-25. Follow-up analysis of some of these signals by LC-MS/MS and RNA expression profiling revealed both concordance and discordance of RNA and protein expression. This study demonstrates that this procedure is highly reliable for identifying peptides that distinguish biological variability among samples, indicating that this method can be applied to study clinical samples, to identify potential prognostic biomarkers for HNSCC.",
keywords = "Biomarker, Cancer, Global proteomics, Squamous cell carcinoma",
author = "Rajagopalan Sudha and Nicole Kawachi and Peicheng Du and Edward Nieves and Belbin, {Thomas J.} and Abdissa Negassa and Angeletti, {Ruth Hogue} and Prystowsky, {Michael B.}",
year = "2007",
month = "8",
day = "11",
doi = "10.1038/labinvest.3700598",
language = "English (US)",
volume = "87",
pages = "755--766",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma

AU - Sudha, Rajagopalan

AU - Kawachi, Nicole

AU - Du, Peicheng

AU - Nieves, Edward

AU - Belbin, Thomas J.

AU - Negassa, Abdissa

AU - Angeletti, Ruth Hogue

AU - Prystowsky, Michael B.

PY - 2007/8/11

Y1 - 2007/8/11

N2 - The goal of this study was to establish a method for detecting biologically significant differences in protein expression of head and neck squamous cell carcinoma (HNSCC) obtained from the same samples utilized in gene expression analyses. Proteins from two head and neck tumor cell lines, SCC-25 and FaDu, were isolated from the denatured protein solution remaining from the TRIzol extraction procedure used for isolation of total RNA for microarray analysis. Peptides resulting from chemical and enzymatic digestion of the proteins were first separated by strong cation-exchange chromatography, followed by liquid chromatography-mass spectrometry (LC-MS) analysis on a QqTOF mass spectrometer. Stable isotope-labeled synthetic peptides were added to each ion-exchange fraction as internal standards, for reversed-phase HPLC retention time alignment. Protein extraction and digestion were repeated three times for each cell line and each extract was analyzed three times by LC-MS. To discriminate between technical vs biological variation, the ion-exchange fraction, retention time, normalized mass and signal intensity of these nine data sets were constructed into numerical arrays for statistical analysis. Of the ∼50 000 signals, 90 peptide ions were found to discriminate the two cell lines with high stringency. Of those, six peptides were derived from vimentin and four peptides were derived from annexin II; both expressed more in SCC-25. Follow-up analysis of some of these signals by LC-MS/MS and RNA expression profiling revealed both concordance and discordance of RNA and protein expression. This study demonstrates that this procedure is highly reliable for identifying peptides that distinguish biological variability among samples, indicating that this method can be applied to study clinical samples, to identify potential prognostic biomarkers for HNSCC.

AB - The goal of this study was to establish a method for detecting biologically significant differences in protein expression of head and neck squamous cell carcinoma (HNSCC) obtained from the same samples utilized in gene expression analyses. Proteins from two head and neck tumor cell lines, SCC-25 and FaDu, were isolated from the denatured protein solution remaining from the TRIzol extraction procedure used for isolation of total RNA for microarray analysis. Peptides resulting from chemical and enzymatic digestion of the proteins were first separated by strong cation-exchange chromatography, followed by liquid chromatography-mass spectrometry (LC-MS) analysis on a QqTOF mass spectrometer. Stable isotope-labeled synthetic peptides were added to each ion-exchange fraction as internal standards, for reversed-phase HPLC retention time alignment. Protein extraction and digestion were repeated three times for each cell line and each extract was analyzed three times by LC-MS. To discriminate between technical vs biological variation, the ion-exchange fraction, retention time, normalized mass and signal intensity of these nine data sets were constructed into numerical arrays for statistical analysis. Of the ∼50 000 signals, 90 peptide ions were found to discriminate the two cell lines with high stringency. Of those, six peptides were derived from vimentin and four peptides were derived from annexin II; both expressed more in SCC-25. Follow-up analysis of some of these signals by LC-MS/MS and RNA expression profiling revealed both concordance and discordance of RNA and protein expression. This study demonstrates that this procedure is highly reliable for identifying peptides that distinguish biological variability among samples, indicating that this method can be applied to study clinical samples, to identify potential prognostic biomarkers for HNSCC.

KW - Biomarker

KW - Cancer

KW - Global proteomics

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=34447578784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447578784&partnerID=8YFLogxK

U2 - 10.1038/labinvest.3700598

DO - 10.1038/labinvest.3700598

M3 - Article

VL - 87

SP - 755

EP - 766

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 8

ER -